The initiative is intended to support fishermen and watermen by creating new and better markets for invasive catfish while strengthening rural food supply chains.
The plant is fully operational and designed to produce both mash and pelleted feed.
GMP+ certification is one of the most recognised and respected quality assurance systems in the global animal feed industry.
The investment will expand production capacity, meet growing demand and strengthen supply resilience in growing feed markets.
The site is the company’s first ground-up factory in more than 50 years.
The solar-powered, off-grid facility can store about 40 million vaccine doses, helping protect them from power outages.
The site expansion bolsters Elanco’s monoclonal antibody (mAb) production; supports delivery of next-generation pipeline.
The project will repurpose a 463,503-square-foot fermentation facility at ADM’s Clinton complex.
The facility is expected to open by the end of 2026.
The facility is expected to produce approximately 20 to 30 tonnes of giant grouper annually.